CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA
Clinical trials for CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA explained in plain language.
Never miss a new study
Get alerted when new CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA trials appear
Sign up with your email to follow new studies for CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare heart condition: AGP100 trial aims to tame dangerous rhythms
Disease control Recruiting nowThis study tests a new drug, AGP100, in 10 adults with a rare inherited heart condition called CPVT, which can cause dangerously fast heartbeats during exercise or stress. Participants take three different doses of AGP100 alongside their usual medication over six weeks, with hosp…
Matched conditions: CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA
Phase: PHASE2 • Sponsor: Agiana Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 03:10 UTC
-
New drug could tame rare 'Exercise-Triggered' heart condition
Disease control Recruiting nowThis study tests an experimental drug called CRD-4730 in 12 adults with a rare genetic heart condition (CPVT) that can cause dangerous heart rhythms during exercise or stress. Each participant will receive two different doses of the drug and a placebo in random order to see if it…
Matched conditions: CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA
Phase: PHASE2 • Sponsor: Cardurion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Gene therapy trial aims to tame deadly Exercise-Induced heart rhythms
Disease control Recruiting nowThis early-stage study tests the safety of a single dose of SGT-501, a gene therapy for people with catecholaminergic polymorphic ventricular tachycardia (CPVT), a rare inherited heart condition that can cause dangerous heart rhythms during exercise or stress. The trial will enro…
Matched conditions: CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA
Phase: PHASE1 • Sponsor: Solid Biosciences Inc. • Aim: Disease control
Last updated May 08, 2026 12:02 UTC
-
Brazil launches massive heart gene hunt
Knowledge-focused Recruiting nowThis study will enroll 1,211 people in Brazil who have inherited heart conditions like cardiomyopathy or long QT syndrome. Researchers will collect DNA samples and medical information to find out which genes are most commonly affected in this population. The goal is to better und…
Matched conditions: CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA
Sponsor: Hospital do Coracao • Aim: Knowledge-focused
Last updated May 17, 2026 02:58 UTC